Most research on firm financing studies the choice between debt and equity. We model an alternative source -non-core asset sales -and allow asset sales to occur for operational as well as financing motives. We identify three new factors that drive a firm's choice between selling assets and equity. First, equity investors own a claim to the cash raised. Since cash is certain, this mitigates the information asymmetry of equity (the "certainty effect"). In contrast to This result is robust to using the cash for an uncertain investment. Second, firms can disguise the sale of a low-quality asset as instead being motivated by operational reasons (dissynergies), and thus receive a high price (the "camouflage effect"). Third, selling equity implies a "lemons" discount for not only the equity issued but also the rest of the firm, since its value is perfectly correlated. In contrast, a "lemons" discount on assets need not lead to a low stock price, as the asset is not a carbon copy of the firm (the "correlation effect").
No takes yet. Share an insight, caveat, or question.
Edmans et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: